A phase 1/2 study of the next-generation nectin-4-targeting antibody-drug conjugate CRB-701 (SYS6002) in patients with recurrent or metastatic cervical cancer

Autores de IIS La Fe

• Guillermo Suay Montagud

  Autor

Participantes ajenos a IIS La Fe

• Ciuleanu, TE
• Berton, D
• Daniele, G
• Gales, LN
• Tosi, D
• Curigliano, G
• Lostes-Bardaji, MJ
• Antonuzzo, L
• de Spéville, BGD
• Volovat, CD
• Josephs, D
• Pinato, DJ
• Ackroyd, SA
• Barrera, I
• Preugschat, K
• Grant, PM
• Hodgson, I
• Smethurst, D
• Loriot, Y

Grupos

• Unidad de Biomarcadores y Medicina de Precisión (UBYMP)

Abstract

Abstract no disponible